 Home > Active Ingredient News > Antitumor Therapy > Express $700 million to help develop anti-cancer bispecific nanoantibodies! Seagen reached a partnership

Express $700 million to help develop anti-cancer bispecific nanoantibodies! Seagen reached a partnership

 Last Update: 2022-10-01
 Source: Internet
 Author: User

▎Editor of WuXi AppTec content team

Seagen today announced an exclusive licensing agreement with LAVA Therapeutics, which will jointly develop, manufacture and commercialize the in-development bispecific VHH LAVA-1223

LAVA's proprietary Gammabody platform is a technology for the development of spot-based bispecific nanoantibodies targeting Vγ9Vδ2 T cells and tumor-associated antigens

▲Gammabody platform (Image source: LAVA official website)

LAVA-1223, developed through the Gammabody platform, can specifically target solid tumors expressing EGFR and activate Vγ9Vδ2 T cells

Under this agreement, Seagen will be granted the exclusive global license of LAVA-1223 and will pay an advance payment of $50 million from LAVA, with a total of up to $650 million based on developmental, regulatory and commercial milestones

"Seagen is committed to fostering innovative therapies to improve the lives of

WuXi AppTec provides integrated, end-to-end new drug development and manufacturing services to the global biopharmaceutical industry, covering the fields

▲If you have any business needs, please long press to scan the QR code above, or

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.